首页
订购/客服:400-666-5481

CDK4/6-IN-15

    
≥98%

源叶(MedMol)
V45692 一键复制产品信息
2078047-99-9
C21H27FN8S
442.56
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V45692-1mg
≥98%

¥1350.00

货期:3-5天 - - - -
V45692-5mg
≥98%

¥2990.00

货期:3-5天 - - - -
V45692-10mg
≥98%

¥4790.00

货期:3-5天 - - - -
V45692-25mg
≥98%

¥8630.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: CDK4/6-IN-15 is an orally active and selective CDK4/6 inhibitor. CDK4/6-IN-15 potently inhibits cancer cells growth. CDK4/6-IN-15 arrests cell cycle at G1 phase and suppresses retinoblastoma tumour suppressor protein (Rb) phosphorylation at S780 and E2 factor (E2F)-regulated gene expression.
体外研究: CDK4/6-IN-15 (compound 91) (10 μM; 24 h) also potently inhibits FLT3 and MYLK4 with inhibition rates >90%.
CDK4/6-IN-15 (0-5 μM; 72 h) suppresses tumour cell proliferation selectively with GI50s of 0.107 μM (MV4-11) and 0.325 μM (MDA-MB-453).
CDK4/6-IN-15 (0.1-1 μM; 24 h) arrests exclusively the cell cycle at G1 phase in Rb-positive MV4-11 cells and MDA-MB-453 cells.
CDK4/6-IN-15 (0.1-1 μM or 0.3-3 μM; 24-96 h) triggers apoptosis in MV4-11 and MDA-MB-453 cells.
CDK4/6-IN-15 (0.1-3.3 μM; 4-24 h) inhibits phosphorylation of Rb.
体内研究: CDK4/6-IN-15 (compound 91) (2 mg/kg for i.v. or 10 mg/kg for p.o.; single dose) shows comparable oral absorption in healthy male adult BALB/c mice (20-25 g) as well as (5 mg/kg for i.v. or 200 mg/kg for p.o.; single dose) in male albino Wistar rats (250-3￿웿￿￿Ů
保存条件: 2-8°C, 避光
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.26 ml 11.298 ml 22.596 ml
5 mM 0.452 ml 2.26 ml 4.519 ml
10 mM 0.226 ml 1.13 ml 2.26 ml
50 mM 0.045 ml 0.226 ml 0.452 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×